TWD 20.25
(-10.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 25.84 Million TWD | 9.3% |
2022 | 23.64 Million TWD | -39.21% |
2021 | 38.89 Million TWD | 84.3% |
2020 | 21.1 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 5.2 Million TWD | -64.74% |
2024 Q1 | 14.76 Million TWD | 171.3% |
2023 Q1 | 3.64 Million TWD | -13.56% |
2023 Q4 | 5.44 Million TWD | -20.67% |
2023 FY | 25.84 Million TWD | 9.3% |
2023 Q2 | 9.89 Million TWD | 171.45% |
2023 Q3 | 6.86 Million TWD | -30.68% |
2022 Q4 | 4.21 Million TWD | 0.0% |
2022 FY | 23.64 Million TWD | -39.21% |
2021 FY | 38.89 Million TWD | 84.3% |
2020 FY | 21.1 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Anti-Microbial Savior BioteQ Co., Ltd | 728 Thousand TWD | -3450.412% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 1.11 Billion TWD | 97.681% |
Level Biotechnology Inc. | 660.61 Million TWD | 96.087% |
Sagittarius Life Science Corp | 440.46 Million TWD | 94.132% |
NeoCore Technology Co., Ltd. | 64.72 Million TWD | 60.069% |
TaiMed Biologics Inc. | 491.77 Million TWD | 94.744% |
GlycoNex Incorporation | 2.54 Million TWD | -916.798% |
VBI | 55.85 Million TWD | 53.723% |
GeneReach Biotechnology Corp. | 225.46 Million TWD | 88.536% |
Taiwan Advance Bio-Pharmaceutical Inc. | 315.98 Million TWD | 91.82% |
SynCore Biotechnology Co.,Ltd | 20.19 Million TWD | -27.981% |
Genomics BioSci & Tech. Co.,Ltd. | 396.14 Million TWD | 93.475% |
Visgeneer Inc. | 147.99 Million TWD | 82.535% |
Mycenax Biotech Inc. | 652.62 Million TWD | 96.04% |
Sunmax Biotechnology Co., Ltd. | 1.68 Billion TWD | 98.47% |
G&E Herbal Biotechnology Co., Ltd. | 181.44 Million TWD | 85.755% |
Neith Corporation | 39.9 Million TWD | 35.225% |
Medigen Vaccine Biologics Corporation | 389.62 Million TWD | 93.366% |
TaiwanJ Pharmaceuticals Co., Ltd. | 22.74 Million TWD | -13.653% |
Enimmune corporation | 43.49 Million TWD | 40.573% |
TaiRx, Inc. | 5.08 Million TWD | -408.599% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 1.02 Billion TWD | 97.473% |
BioLASCO Taiwan Co., Ltd. | 264.72 Million TWD | 90.236% |
Sunny Pharmtech Inc. | 428.82 Million TWD | 93.973% |
Lin BioScience, Inc. | - TWD | -Infinity% |
BioGend Therapeutics Co., Ltd. | 109.9 Million TWD | 76.483% |
Feng Chi Biotech Corp. | 180.57 Million TWD | 85.687% |
Bio Preventive Medicine Corp. | 1.2 Million TWD | -2039.652% |
Lukas Biomedical Inc. | 231.83 Million TWD | 88.851% |
RBC Bioscience Corporation | 172.46 Million TWD | 85.013% |
BiOptic Inc. | 228.26 Million TWD | 88.677% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -28618.889% |
Shine-On BioMedical Co.,Ltd. | 9.52 Million TWD | -171.388% |
Great Novel Therapeutics Biotech & Medicals | 4.85 Million TWD | -432.928% |
Syngen Biotech Co.,Ltd. | 1.83 Billion TWD | 98.593% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 22.48 Million TWD | -14.973% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 141.17 Million TWD | 81.692% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 805 Thousand TWD | -3110.807% |
Greenyn Biotechnology Co., Ltd | 800.51 Million TWD | 96.771% |
Lumosa Therapeutics Co., Ltd. | 56.91 Million TWD | 54.587% |
AP Biosciences Inc | 32.25 Million TWD | 19.862% |
Medigen Biotechnology Corp. | 1.15 Billion TWD | 97.767% |
3D Global Biotech Inc. | 20.63 Million TWD | -25.27% |
Pharmosa Biopharm Inc. | 314.5 Million TWD | 91.782% |
Oneness Biotech Co., Ltd. | 86.78 Million TWD | 70.217% |
Eusol Biotech Co.,Ltd. | - TWD | -Infinity% |
TWi Biotechnology, Inc. | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 758.39 Million TWD | 96.592% |
TCI GENE Inc. | 333.85 Million TWD | 92.258% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -143494.444% |
Senhwa Biosciences, Inc. | 1 Million TWD | -2484.7% |
Taiwan Bio Therapeutics Co., Ltd | 85.47 Million TWD | 69.759% |
NatureWise Biotech & Medicals Corporation | 160.14 Million TWD | 83.86% |
PharmaEngine, Inc. | 767.66 Million TWD | 96.633% |
Savior Lifetec Corporation | 1.05 Billion TWD | 97.539% |
TaiGen Biopharmaceuticals Holdings Limited | 123.13 Million TWD | 79.009% |
OBI Pharma, Inc. | 41.54 Million TWD | 37.792% |
Meribank Biotech Co., Ltd | 234.34 Million TWD | 88.97% |
Acepodia, Inc. | 16.59 Million TWD | -55.771% |
Caliway Biopharmaceuticals Co., Ltd. | 38.93 Million TWD | 33.61% |